Proteomics represented vital applications of technologies in the identification and quantification of high to moderate proteins (cellular signalling networks) found in biological matrix such as tissues, cells and fluids. Proteomics based technical knowledge is applied and verified in several preclinical research settings such as invention of diagnostic markers for specific disease and have shown to be increased in clinical applications. Extensive studies on proteomics resulted in detection of biomarkers that have been highly advanced in using diseases for cancer, lungs, cardiovascular, renal and neuro-regenerative and Parkinson's disease by introducing human origins for biocompatibility such as urine and serum. Advancement in the proteomic methods is conferring candidate right direction for clinical usage. In this review, recent developments and widely used proteomics approaches such as Mass Spectrometry (MS), Microarray chips are elaborately addressed and also focused merits and demerits of commonly used advanced approaches such as Selected Reaction Monitoring (SRM), Parallel Reaction Monitoring (PRM) and Data Independent Acquisition (DIA) and other used proteomics and that roles, in order to aid clinicians, were also discussed in the light of biomedical applications.
INTRODUCTION
To date, in biomedical, molecular biology and clinical applications (Medicine), a wide range of latest validation tools are used for disparating proteins on gels and detecting therapeutic target by applying lasers technology, and they have emerged as innovative, versatile science division and is referred as Proteomics. It is an analytical pattern in wide ranges to identify, measure and understand post translational concerning of protein in a tissue or cell or body fluid. 1 Proteomic approaches represented an instrumental in providing information of diseases on molecular basis, clear understanding of pathophysiology, prediction of disorders thereby conferred standardized thrust, aiming at therapeutic solutions. Proteomic tools contribute a new clarity for health risk factors and have been recognized as a novel science instead of collection of tools. 2 Proteome indicated a set of proteins generated or altered by a living organism on biological systems, responsible for functional information of genes.
Proteomics considered to be a key for detecting disease in early stage, while prevention is still possible. It has played a crucial role in prognosis, diagnosis and to examine the developing disorders. In Greek, diagnosis means "capable of recognition" whereas prognosis represents "to know in advance". To determine relevant therapeutic treatment, early diagnosis is considered to be crucial. Proteomics is instrumental in characterizing "proteome" covering expression, functional pattern and association of proteins in any form. 3 Proteomics have shown to be highly dynamic and exhibited instability with response to an external stimulus in each cell. In identifying and to understand gene function, proteomics has shown more complexity compared to genomics. 4 Such deterioration is able to predict and measure entire transcription using Microarray chips that have been adopted for an extensive examination.
The main objectives of the proteomics include (a) to receive integrated aspects of biology by understanding entire cell protein network instead of individual protein (b) this does not indicate mere identifying protein but to understand the structure, function and to evolve 3D Map of cell to determine individual gene expression
REVIEW OF LITERATURE
The structure affinity and the role of each protein within cells and living organisms could be detected by using advanced methods of protein measures. These computational results would also be claimed to body fluids to derive information as biomarkers to help health care providers and scientists for better understanding of dynamic system such as cancer affected subjects. 5 Therefore, in the present mini review, understanding of current applications and recent advancement in proteomics in the field of biomedical, molecular biological research and advanced, feasible and most commonly used methodology and applications covering MS, Biomarkers, Microarray chips and other latest techniques under usage have been discussed in detail by compiling published sources.
Biomarker -an application of proteomics
A biomarker basically represents a protein that closely associated with disease and acts as a disorder index to diagnose, prognosis and examine the disease changes resulting to evolve strategy for therapeutic target. 6 Basic methods used in Biomarkers in clinical settings, a tiny or traceable quantity of substances are injected into the organisms to track and to know the interaction and function in health-related risks.
Usually, in clinical settings, PSA (Prostate-Specific Antigen) has been used as a biomarker for cancer detection. In many cases, malignancy disease is detected at very late at the severe stage, may be due to poor awareness and remain expensive and time consuming to determine biomarker. Therefore, throughput analyzing method has been developed for earlier detection. Proteomic technique often applied in identifying biomarkers, by searching a global protein profiling in blood, urine or body fluids, in order to find out disease-specific biomarkers using proteomics. The commonly used approach in identifying biomarker is found to be a 2D PAGE, that provides information on the association between normal and disease-affected proteins. 7 The classification of biomarkers categorized based on disease specificity and information was given by them.
They are categorized as diagnostic, prognostic and treatment predictive biomarkers. Similar bifurcation can also be applied to drug design. 8 Another study report estimated that 2% of human diseases evolved from gene damage, rest account for 98% attributed to the environmental factors that participating in disease development. In this context, proteomics implicates and act on identifying disease-associated protein that also participates in the development of the disease (Table 1) .
However, very few identified biomarkers were validated and approved by the FDA for use in clinical trials. 9 The potential for profiling protein in biological fluids such as blood, serum, nipple aspirate and urine using proteomic tools, is possible to identify large scale species at a time and enables to find out appropriate biomarkers for cancer subject. In earlier, biomarkers were invented by adopting conventional methodology such as Enzyme Linked Immuno-sorbent Assay (ELISA), Western blotting, Gel electrophoresis whereas present scientific era has approached proteomics for biomarker detection using 2D PAGE, Mass spectrometry (MALDI), Electrospray ionization and SELDITOt. Two bottom-up proteomic techniques were employed to determine and ascertain the extracted proteins. 10 It is noteworthy to state that the validation phase of biomarker discovery receives extensive attention as it needs clinical testing to be evaluated. 11, 12 In recent literature Norman et al, reported that Aptamere, a short single strand RNA binding had specific site of target organism with maximum specificity and strong association and one of the classes of Aptamer (SOMAmer) has been shown to be very effective as biomarker tools in several diseases covering lung cancer, pulmonary tuberculosis and IPF. [13] [14] [15] [16] [17] [18] [19] [20] 
Mass Spectrometry (MS) based proteomics
To accuracy, reliability manifested for analyzing the protein sample, the Mass Spectrometry is only choice and significant proteomic tool to measure with improved ability in excess scale of protein in biological fluids.
Using MS, variation of the protein in the given sample, identified based on their mass and charge (m/z). 21, 22 Presently, two transforming technologies are prevalent in rapid development of protein related studies. Of these, one of the novel strategies for sequencing polypeptide using MS including ionization techniques that cover Electroscopic Ionization [ESI] and Matrix Assisted Laser Desorption (MALDI) followed by automation of liquid chromatography. By employing these techniques, we enable to measure and discover novel peptides on a range with extraordinary number of sequences per day with good femto-molar sensitivity in biological matrix. In recent, a diverse number of research problems else from expression of protein profiling to test signaling pathways and to develop disease specific biomarkers.
In this context, a specific strategy for each, a question arises and still remaining unanswered. Consequently, authors keep in mind, when considering designing a study, among existing variable measures, however, a promising application oriented and candidate result providing and routine working device can be preferred and applied.
When characterizing a protein, prior to initiate, it needs to assess and select technical determinants such as sample size (amount of sample), purity and nature of solubility of the given protein materials. In MS, intact protein sample can be measured with an accuracy within the range of 0.01% and can divide interactive ability or affinity of isolated protein can be covered. MS contributes a measure of purity at the level of <5% contaminants in protein preparation. Such factors are absolutely mandatory for preparing medicated proteins and to proceed structural analysis using Nuclear Magnetic Resonance (NMR).
The size of the protein such as 150 kDa and insoluble protein are exhibited provocative. As maximum insoluble mass disrupts in MS signaling and minimize the detection ability. Therefore, we are sure, on sequencing peptides using MS, as it determines 'N' terminus of the protein. 23 This method can also be performed to identify the proteins from splice variants and single-nucleotide polymorphism, however, to analyze entire complex biological materials using MS is dependent on 2 Dimensional Gel Electrophoresis (2DGEL) or HPLC that are relationized before operating Mass analysis. 24, 25 HPLC is commonly used methodology for various Liquid Chromatography (LC-MS) and recognized as an instrumentation platform for the research. 26 Although, both measures possess demerits and highlights, but still, we often use both in molecular and therapeutic approaches. Presently, electron capture dissociation has been recognized for an alternate complementary fragmentation technology which includes Orbitrap with a high resolution testing, adding with resolution time of flight mass spectrometer. 27, 28 MS has been novel and commonly used for several biomarker investigations on respiratory diseases such as chronic obstructive pulmonary disease was reported. Acute respiratory syndrome was also detected using mass spectroscopic studies (Figure 1 ). 29
Figure 1: Basic aspects and applications of mass spectrometry.

Current trends in proteomic applications
PRM, SRM and DIA cellular signaling network
With remarkable advancement in MS instrumentation, huge number of promising biomarkers have been produced from various proteomics investigations, however, nothing has succeeded in FDA approved clinical testing which might have attributed to the scarcity of appropriate protein quantification instruments, enable to measure huge number of promising protein biomarkers (1000 human samples). 30 [34] [35] [36] [37] SRM is outstanding proteomic approach functioning on a triple quadrupole mass spectrometer (QqQMS). 34 This utilizes characteristics of QqQ with two level mass selection (Q1 and Q3) and showed prolonged dwell time resulting in a remarkable improvement in selectivity and higher sensitivity higher than complete scan global proteomic testing. It exhibited similar concepts as in western blotting. 38 
Protein microarray chips
Protein microarrays referred as Protein chips that are coming under class of proteomics techniques to identify high throughput in a little quantity of sample. Protein micro assay can be grouped and bifurcated into three sections such as (a) Analytical (b) Functional and (c) Reverse-phase protein microarray. This has been instrumental in establishing protein expression examination. However, it seems to be inadequate to expose entire genome function. 39 While, MS spectroscopy was developed for different proteomic approaches to test highly sensitive protein mixture. 40 Subsequently, Edman degradation has been produced to ascertain the amino acid sequential settings for a specific protein. 41 In recent times, for quantification of protein, the methods such as Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids (SILA) in cell culture is often used. Similarly, isobaric tag for relative and absolute quantification (iTRAQ) techniques were evolved for quantification measurements. The technique such as X-ray crystallography and nuclear magnetic resonance)/ (NMR) spectroscopy are an indicator of high throughput technique that is widely used to derive three dimensional structure of protein.
Using X-ray crystallography and NMR Spectroscopy technique a large volume of databases can be collected. Meanwhile enormous bioinformatic data are available as it stores. Several types of bioinformatic tools are developed for 3D structure prediction such as protein domain, motif testing, examining protein to protein affinity or repel followed by data analysis on MS. Alignment tools help to expose evolutionary trends of given protein. 42, 43 
Analytical protein microarray
This class represented by antibody microarray. Antibody microarray bestows direct protein leveling followed by antibody capture and this method is often applied to determine the expression level and interaction of protein between them. 44, 45 A substantial evident that High Throughput Proteome Testing of cancer cell was practiced, using antibody microarray method to bring out varied protein expression in tissues from oral cavity of carcinoma affected patient. 46 Another study reported that this method could also be used for protein profiling of bladder cancer. 47 Inventory of cellular signaling pathways using experimental approaches were developed to characterize kinase from plant source applying protein microarray was also reported. 48 
Functional microarray
The quantity of individual protein is influenced by transcription determinants. These determinants that invade nucleus and bind with particular DNA System. This proteomic support to elucidate and stimulating enzyme action resulted powerful regulating growth process and differentiation of cells. This also helps to explain the process of ageing. Functional Micro array represented the study of several interactive patterns such as protein-DNA, RNA with protein, in between protein, affinitive with drugs, lipid and protein and enzyme substrate association as they are made of purified protein. Primary application of functional microarray was to test substrate specificity of protein kinase. 49 This functional microarray method contributes functions of huge number of proteins.
Reverse-phase protein microarray
This approach used to identify the defective and dysfunctional protein, an indicator of onset of disease. The reverse phase approach was assessed for quantification of phosphoprotein and other carcinoma disease associated protein in non-small lung cancer cell lines approaches. It examines apoptosis, DNA damage and involving various signaling pathways. 50 
Proteomic of the disease
This plays a role in capturing pathology at each stage of diseases to decide more accurate etiopathogenesis and confers information on the mechanism of diseases such as cancer, neurodegenerative diseases, inflammatory and genetic metabolic diseases. Proteomic would confer information on defective signaling pathways in cellular level was reported. 51 
Clinical proteomic
This proteomic is to achieve proteins that can be often used for diagnosis biomarkers since their expression is increased in certain physiologic and pathologic conditions such as infectious cancerous and inflammatory conditions. In case of sensitivity and specificity parameters, proteomic markers showed better option than Onome members.
Pharmacoproteomic
In clinical settings, efficiency of therapy and toxicity could be examined using protein spectrum fluctuations and their functional effects. SDS-PAGE is a sophisticated wide used resolving method in separating proteins based on their size; protein naturally potential to move towards electric field in a medium with pH with a different velocity towards the electric point. Various types of proteins in a sample of mixture move based on their mass and ratio, besides sodium Dodecyl Sulphate cleaved and denature the proteins and separate them molecular weight basis. 52 A research group studied and reported that in African countries, Cleome spp. were consumable and possess therapeutic value for the treatment of cough, fever, asthma, rheumatism and other related diseases. An analysis of seed and leaf protein were carried out using SDS-PAGE as Brassica spp. 53 Seed Storage proteins are also isolated and identified to access genetic divergence in genotypes. Excess production of insulin is used for controlling of diabetic mellitus have characterized and purified Insulin from Camelus dromedaries.
DISCUSSION
Based on the above discussion, MS and other technologies are certainly contributed to the maximum extent in proteomics emergence, however, recent trends in the development of proteomics include, entry of worthful two targeted methods, PRM and DIA using MS quantifications. However, still needs to overcome certain limitations. SRM method is benefits in excluding required transition selection and optimization. PRM is performing and found to be promising similar effects in sensitive, countless capacity and reliability and in particular selectivity compared to SRM. Eventually, PRM showed a challenging in quantification in measurements. 12, 54 As a result, it is the eleventh hour to design an effective tool with combination of scale and selectivity for excessive proteins to quantify. Disputes, DIA excreted less sensitive, low specificity than other tools (SRM and PRM), it has been used mostly for primary screening of abundant various dynamic proteins. Subsequently, SRM or PRM has been performed for measuring low abundance proteins. Discovery of protein measurements tools with cost effective, maximum limit of measuring ability will provide the right solution for clear understanding of signal transduction network in forthcoming era. 17, 55 Funding: No funding sources Conflict of interest: None declared Ethical approval: Not required
